55
Views
36
CrossRef citations to date
0
Altmetric
Original Article

Patients with Primary Sjögren's Syndrome Treated for Two Months with Evening Primrose Oil

, , &
Pages 103-108 | Published online: 12 Jul 2009

References

  • Avisar R., Menache R., Shaked P., Rubinstein J., Machtey I., Savir H. Lysozyme content of tears in patients with Sjögren's syndrome and rheumatoid arthritis. Am J Ophthalmol 1979; 87: 148
  • Horrobin D. F. Essential fatty acid metabolism in diseases of connective tissue with special reference to scleroderma and to Sjögren's syndrome. Med Hypotheses 1984; 14: 233
  • Manku M. S., Horrobin D. F., Huang Y-S, Manthorpe R., Hagen Petersen S., Prause J. U. Abnormal levels of red cell fatty acids in primary Sjögren's syndrome: partial correction by essential fatty acid supplementation with evening primrose oil. Med Hypotheses, [in press]
  • Manku M. S., Horrobin D. F., Huang V., Morse N., Jenkins K., Kyte V., Grimes S., Kirby J. D. T. Essential fatty acid and prostaglandin levels in patients with systemic sclerosis complicated by Raynaud's phenomenon during treatment with evening primrose oil or placebo, [submitted to J Rheumatol]
  • Manthorpe R., Frost-Larsen K., Isager H., Prause J. U. Sjögren's syndrome. A review with emphasis on immunogical features. Allergy 1981; 36: 139
  • Manthorpe R., Hagen Petersen S., Prause J. U. Primary Sjögren's syndrome treated with Efamol/Efavit. Rheumatol Int 1984; 4: 165

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.